市場調查報告書
商品編碼
1471957
脊椎植入物市場規模和預測、全球和區域佔有率、趨勢和成長機會分析報告範圍:按產品、程序、材料、最終用戶和地理位置Spinal Implants Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product, Procedure, Material, End User, and Geography |
脊椎植入物市場規模預計將從2023年的118.8億美元成長到2031年的196.8億美元;預計2023年至2031年複合年成長率為6.5%。
脊椎植入物市場的市場促進因素
近年來,由於手術方法的創新,全球範圍內進行的脊椎植入手術有所增加。技術的發展導致了各種各樣的椎間設備的引入。新推出的用於脊髓手術的設備現在被用作骨移植材料的替代品。隨著脊椎植入技術的進步,椎弓根螺釘現在被用於後路器械。同樣,針對不同手術適應症、外科醫生偏好和患者狀況設計的脊椎融合方法的引入,顯著導致了脊椎植入手術數量的增加。這些融合手術是使用獨立融合器經由前路、側方或後路入路進行椎間融合。根據骨與關節外科醫生協會 2023 年 2 月在 Wolters Kluwer(臨床骨科及相關研究雜誌)上發表的一項研究,到 2060 年,後路脊椎融合手術的需求預計將成長 80%。的肌肉量損失有關。因此,脊椎植入手術數量的增加促進了脊椎植入物市場的成長。
脊椎植入物市場的趨勢
醫療技術的發展促進了脊椎產業的多項創新。隨著機器人手術的發展,脊椎手術領域也受到了廣泛關注。 3D 列印正在擴大其在醫療設備中的足跡,以提供有效的植入物。該公司已經開始開發用於脊椎融合的 3D 列印植入物,並將其商業化。 2021 年 7 月,Orthofix Medical 推出了其 3D 列印骨科設備 FORZA Ti PLIF 間隔系統。此系統專為後路腰椎椎間融合 (PLIF) 手術而設計。在推出 FORZA Ti PLIF Spacer 系統時,該公司也宣布推出首款使用腰椎椎間裝置的病患植入物。同樣,2021 年 4 月,該公司推出了用於頸椎前路椎間盤切除和融合手術的 Construx Mini Ti 墊片系統。同樣,2023 年 4 月,ZSFab 報告了他們的 3D 列印鈦植入物,具有三週期最小晶格結構,這是一種用於前路頸椎間盤切除和融合的頸椎間盤。 ZSFab 在美國的兩個臨床病例中顯示出陽性結果。 2021年,該系統獲得FDA 510(k)許可;該裝置的目的是在去除受損椎間盤後支持兩塊椎骨的融合。許多公司已排隊推出他們的 3D 列印產品。開發成果使得針對患者的 3D 列印植入物增加手術結果的潛在益處。 2022 年 6 月,Aurora Spine 的 Dexasolo-L 脊椎融合系統獲得 FDA 510(k) 許可。 Dexasolo-L 脊椎融合系統是根據患者的骨密度和品質進行設計和個性化的。該系統是腰椎市場首個系統,預計很快就會推出。因此,個人化 3D 列印植入物將使針對複雜畸形的微創方法越來越多,並降低患者風險,促進正面的結果。 3D列印技術的優點包括提高脊椎手術的安全性和效率。它將允許外科醫生根據術前成像來預先計劃手術。 3D列印植體的另一個優點是它們可以減少螺絲-骨界面的應力,從而將植體失敗和不癒合的風險降到最低。因此,一旦3D列印植入物廣泛應用,3D列印技術可望擁有廣闊的前景。
脊椎植入物市場:細分市場概述
依產品分類,市場分為融合脊椎植入物和非融合脊椎植入物。融合脊椎植入物領域在 2023 年佔據最大的市場佔有率,預計在預測期內複合年成長率最高。
市場依手術方式分為椎間孔切開術、椎板切除術、椎間盤置換術、脊椎融合術和椎間盤切除術。椎板切除術領域在 2023 年佔據最大的市場佔有率,預計脊椎融合術在預測期內複合年成長率最高。
脊椎植入物市場依材料分為鈦、碳纖維和不銹鋼。不銹鋼細分市場在 2023 年佔據最大的市場佔有率,預計在預測期內複合年成長率最高。
脊椎植入物市場依最終用戶分為醫院、診斷和影像中心等。到 2023 年,醫院細分市場佔據最大的脊椎植入物市場佔有率,預計在預測期內複合年成長率最高。
脊椎植入物市場:地理概述
據估計,2023 年至 2031 年亞太地區的複合年成長率最高。印度和中國等亞太國家擁有脊椎植入物市場的巨大成長潛力。 2023年,北美佔據最大的脊椎植入物市場。最新醫療設備技術的不斷採用、脊椎損傷的高發病率以及主要參與者的產品創新都有助於北美脊椎植入物市場規模的擴大。例如,根據克利夫蘭診所的數據,在美國,每年約有 18,000 例新的外傷性脊髓損傷病例,即每百萬人口約 54 例脊髓損傷。此外,與年齡相關的磨損引發了美國老年人群中腰痛(LBP)的流行,這反過來又刺激了對脊椎手術和植入設備的需求。據國家衛生服務中心稱,到 2022 年,美國 LBP 的終生發病率為 60-90%,年發病率為 5%。消息來源也指出,每年有 14.3% 的新患者因腰痛就診,約 1,300 萬人因慢性腰痛就診。因此,脊髓損傷和腰痛的高盛行率有利於脊椎植入物市場的發展。
A few of the major primary and secondary sources referred to while preparing the report on the spinal implants market are the World Bank Data, National Health Service (NHS), FDA (Food and Drug Administration), EMA (European Medicines Agency), and WHO (世界衛生組織).
註 - 將為以下提到的地區/國家提供類似的分析
The spinal implants market size is expected to grow from US$ 11.88 billion in 2023 to US$ 19.68 billion by 2031; it is anticipated to record a CAGR of 6.5% from 2023 to 2031.
Market Drivers of the Spinal Implants Market
In recent years, there has been a rise in spinal implant procedures performed worldwide due to innovations in surgical approaches. Technological developments have resulted in the introduction of a wide variety of interbody devices. The newly introduced devices for spinal cord surgeries are now used as alternatives in bone graft materials. With advancements in spinal implant techniques, pedicle screws are now being used for posterior instrumentation. Similarly, the introduction of spinal fusion methods designed for different surgical indications and, surgeon preferences, and patient conditions has significantly resulted in a rise in the number of spinal implant procedures. These fusion procedures are performed with interbody fusion using stand-alone cages and with anterior, lateral, or posterior approaches. According to a study published in Wolters Kluwer (Clinical Orthopaedics and Related Research Journal) by the Association of Bone and Joint Surgeons in February 2023, the demand for posterior spinal fusion procedures is expected to grow by 80% by 2060. An upsurge in the procedures can be associated with the age-related loss of muscle mass. Thus, an increase in the number of spinal implant procedures bolsters the spinal implants market growth.
Trends in the Spinal Implants Market
Evolution in medical technology has allowed several innovations in the spinal industry. Developments have allowed robotic surgery in the spine surgery arena, which has received much attention. 3D printing is expanding its footprint in medical devices to offer effective implants. Companies have already begun developing 3D-printed implants for spinal fusion and have commercialized them. In July 2021, Orthofix Medical launched its 3D-printed orthopedic device, the FORZA Ti PLIF Spacer System. The system is designed for posterior lumbar interbody fusion (PLIF) surgeries. At the launch of the FORZA Ti PLIF Spacer system, the company also announced the first patient implant using the lumbar interbody device. Similarly, in April 2021, the company launched the Construx Mini Ti spacer system for anterior cervical discectomy and fusion procedures. Likewise, in April 2023, ZSFab reported their 3D-printed titanium implant with a triply periodic minimal lattice structure, a cervical interbody system for anterior cervical discectomy and fusion. ZSFab has shown positive results in two US clinical cases. In 2021, the system received FDA 510(k) clearance; the device is intended to support the fusion of two vertebrae after removing the damaged disc. Many companies have lined up to launch their 3D-printed products. Developments allow patient-specific 3D-printed implants to increase potential benefits to surgical outcomes. In June 2022, Aurora Spine received the FDA's 510(k) clearance for its Dexasolo-L spinal fusion system. The Dexasolo-L spinal fusion system is designed and personalized using the patient's bone density and quality. The system is the first in the market for lumbar spine and is expected to be launched soon. Thus, personalized 3D-printed implants will enable increasing minimally invasive approaches for complex deformities and reduce patient risks, promoting positive results. The advantages of 3D-printed technology include improving the safety and efficiency of spine surgery. It will permit surgeons to pre-plan surgery based on preoperative imaging. The other advantage of 3D-printed implants is that they will reduce the stress of the screw-bone interface, resulting in the minimum risk of implant failure and non-union. Thus, 3D printing technology is expected to hold a promising future once 3D-printed implants are used regularly.
Spinal Implants Market: Segmental Overview
By product, the market is bifurcated into fusion spinal implants and non-fusion spinal implants. The fusion spinal implants segment held the largest market share in 2023, and it is anticipated to register the highest CAGR during the forecast period.
The market, by procedure, is categorized into foraminotomy, laminectomy, spinal disc replacement, spine fusion, and discectomy. The laminectomy segment held the largest market share in 2023 and spine fusion is anticipated to register the highest CAGR during the forecast period.
The spinal implants market, by material, is segmented into titanium, carbon fiber, and stainless steel. The stainless steel segment held the largest market share in 2023 and is anticipated to register the highest CAGR during the forecast period.
The spinal implants market, by end user, is categorized into hospitals, diagnostic and imaging centers, and others. The hospitals segment held the largest spinal implants market share in 2023 and is anticipated to register the highest CAGR during the forecast period.
Spinal Implants Market: Geographical Overview
Asia Pacific is estimated to register the highest CAGR during 2023-2031. Countries in the Asia Pacific, such as India and China, hold significant potential for the growth of the spinal implants market. In 2023, North America held the largest spinal implants market share. The growing adoption of the latest medical device technologies, the high prevalence of spinal injuries, and product innovations by key players contribute to the expansion of the spinal implants market size in North America. For instance, According to the Cleaveland Clinic, in the United States, there are about ~18,000 new traumatic spinal cord injury cases each year, which is ~54 cases of spinal cord injury per one million population. Additionally, age-related wear-and-tear triggers the prevalence of lower back pain (LBP) among the geriatric population in the US, which, in turn, fuels the demand for spinal surgeries and implantable devices. According to National Health Services, in 2022, the lifetime incidence of LBP in the US is reported to be 60-90%, with an annual incidence of 5%. The source also states that 14.3% of new patients visit physicians each year because of LBP, and ~13 million people visit physicians due to chronic LBP. Thus, the high prevalence of spinal cord injury and LBP favors the spinal implants market progress.
A few of the major primary and secondary sources referred to while preparing the report on the spinal implants market are the World Bank Data, National Health Service (NHS), FDA (Food and Drug Administration), EMA (European Medicines Agency), and WHO (World Health Organization).
Note - Similar analysis would be provided for below mentioned regions/countries
Note - Similar information would be provided for below list of companies